MedTrace Logo

Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

NCT05070650 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-09-26

No results posted yet for this study

Summary

Prospective, randomized, multinational, multicenter, double-blind trial in 2 parallel groups of patients

Conditions

  • Common Cold

Interventions

DRUG

Acetylcysteine

200 mg/500 mg/10 mg granules for oral solution: one sachet three times per day

DRUG

Paracetamol

500 mg/10 mg granules for oral solution: one sachet three times per day

DRUG

Phenylephrine

500 mg/10 mg granules for oral solution

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-20
Primary Completion
2025-04-30
Completion
2025-04-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070650 on ClinicalTrials.gov